-
1
-
-
0001338850
-
Dram injury, drugs, and environment as causes of mental decay in epilepsy
-
Lennox WG. Dram injury, drugs, and environment as causes of mental decay in epilepsy. AmJ Psychiatry 1942;99:174-80.
-
(1942)
Amj Psychiatry
, vol.99
, pp. 174-180
-
-
Lennox, W.G.1
-
2
-
-
0022902813
-
Mental deterioration in epilepsy
-
Lesser RP, Luders H, Wyllie E. Dinner DS. Moms HH Mental deterioration in epilepsy. Epilepdia 1986;27(Suppl 2):S105-23.
-
(1986)
Epilepdia
, vol.27
, Issue.2
, pp. S105-SS23
-
-
Lesser, R.P.1
Luders, H.2
Wyllie, E.3
Dinner, D.S.4
Moms, H.H.5
-
3
-
-
0000237519
-
-
Devinsky O. Theodore WH, editors. Epilepsy and behavior. New York: Wiley-Li
-
Meador KJ, Lonng DW. Cognitive effects of antiepileptic drugs. In: Devinsky O. Theodore WH, editors. Epilepsy and behavior. New York: Wiley-Li. 1991:151-70.
-
(1991)
Cognitive Effects of Antiepileptic Drugs
, pp. 151-170
-
-
Meador, K.J.1
Lonng, D.W.2
-
4
-
-
0002551980
-
Cognitive effects of epilepsy and of antiepileptic medications
-
In: Wyllie E. editor, 2nd ed. Baltimore: William ft Wilkins
-
Meador KJ. Cognitive effects of epilepsy and of antiepileptic medications. In: Wyllie E. editor. The treatment of epilepsy: Principles and practice. 2nd ed. Baltimore: William ft Wilkins. 1996:1121-30.
-
(1996)
The Treatment of Epilepsy: Principles and Practice
, pp. 1121-1130
-
-
Meador, K.J.1
-
6
-
-
0029866487
-
Theodore WH. Felbamate monotherapy lus stimulant-like effects in patients with epilepsy
-
Ketter TA, Mallow BA, Flamini R, Ko D, White ST, Post RM. Theodore WH. Felbamate monotherapy lus stimulant-like effects in patients with epilepsy. Epilepsy Research 1996:23(2): 129-137.
-
(1996)
Epilepsy Research
, vol.23
, Issue.2
, pp. 129-137
-
-
Ketter, T.A.1
Mallow, B.A.2
Flamini, R.3
Ko, D.4
White, S.T.5
Post, R.M.6
-
7
-
-
0022539206
-
Evaluation of enceplialotropic and psychotropic properties orgabapentin in man by pharmaco-EEG and psychomctry
-
Salem B, Grunherger J, Linzmayer L. Evaluation of enceplialotropic and psychotropic properties orgabapentin in man by pharmaco-EEG and psychomctry. hit J Clin Pharmacol Ther Toxicol 1986(4):362-73.
-
(1986)
Hit J Clin Pharmacol Ther Toxicol
, vol.4
, pp. 362-373
-
-
Salem, B.1
Grunherger, J.2
Linzmayer, L.3
-
9
-
-
0002809374
-
-
Dodrill CB, Arnett JL, Haves AG, Garofalo EA, Greeley CA, Mann ME, et al. Evaluation of quality of life during a double-blind multicenter study of gabapentin (GBP: Neurontin) monotherapy in patients with medically refractory partial seizures (abstract) Epilepsia 1995;36(Suppl 4):88.
-
(1995)
Evaluation of Quality of Life during a Double-Blind Multicenter Study of Gabapentin (GBP: Neurontin) Monotherapy in Patients with Medically Refractory Partial Seizures (Abstract) Epilepsia
, vol.36
, Issue.4
, pp. 88
-
-
Dodrill, C.B.1
Arnett, J.L.2
Havesgarofalo, A.G.3
Greeley, E.A.C.A.4
Mann, M.E.5
-
10
-
-
0029954706
-
Efficacy of gabapentin therapy in children with refractory partial seizures
-
Khurana DS. Riviello J. Hehners S. Holmes G, Anderson J, Mikati MA. Efficacy of gabapentin therapy in children with refractory partial seizures. J Pediatrics 1996;128(6):829-833.
-
(1996)
J Pediatrics
, vol.128
, Issue.6
, pp. 829-833
-
-
Khurana, D.S.1
Riviello, J.2
Hehners, S.3
Holmes, G.4
Erson, J.5
Mikati, M.A.6
-
11
-
-
0030914792
-
Psychomotor agitation following gibapen- tin use in brain injury
-
Childers MK, Holland D. Psychomotor agitation following gibapen- tin use in brain injury. Brain Injury 1997;11(7):537-540.
-
(1997)
Brain Injury
, vol.11
, Issue.7
, pp. 537-540
-
-
Childers, M.K.1
Holland, D.2
-
12
-
-
0030940881
-
Gabapentin and cognition: A double blind, dose ranging, placebo controlled study in refractory epilepsy
-
Leach JP, Girvan J, Paul A, Brodie MJ. Gabapentin and cognition: A double blind, dose ranging, placebo controlled study in refractory epilepsy. J Neurol Neurosurg Psychiatry 1997;62:372-6.
-
(1997)
J Neurol Neurosurg Psychiatry
, vol.62
, pp. 372-376
-
-
Leachgirvan, J.P.1
Paul, J.A.2
Brodie, M.J.3
-
14
-
-
0022409205
-
Lamotrigine (BW430C). A potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam
-
Cohen AF. Ashby L. Crowley D, Land G. Peek AW, Miller AA. Lamotrigine (BW430C). a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam. Br J Clin Pharmacol 1985,20:619-29.
-
(1985)
Br J Clin Pharmacol
, vol.20
, pp. 619-629
-
-
Cohen, A.F.1
Ashby, L.2
Crowley, D.3
Land, G.4
Peek, A.W.5
Miller, A.A.6
-
15
-
-
0027450234
-
Carbama2epine and lamotrigine in healthy volunteers: Relevance to early tolerance and clinical trial dosage
-
Hamilton MJ, Cohen AF, Yuen AW, Harkin N, L G. Weatherley BC, et al. Carbama2epine and lamotrigine in healthy volunteers: relevance to early tolerance and clinical trial dosage. Epilepsia 1993:34: 166-73.
-
(1993)
Epilepsia
, vol.34
, pp. 166-173
-
-
Hamilton, M.J.1
Cohen, A.F.2
Yuen, A.W.3
Harkinweatherley, N.L.G.4
-
16
-
-
0027534819
-
Outcomes ot add-on treatment with lamotrigine in partial epilepsy
-
Smith D, Baker G. Davies G, Dewey M, Chadwick DW. Outcomes ot add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993;34:312-22.
-
(1993)
Epilepsia
, vol.34
, pp. 312-322
-
-
Smith, D.1
Baker, G.2
Davies, G.3
Dewey, M.4
Chadwick, D.W.5
-
17
-
-
0029651761
-
UK Lamotngine/Carbamazepine Monotherapy Trial Group. Double-blind companion of lamotrigine and carbamazepine in newly diagnosed epilepsy
-
(published erratum appears in Lancet 1995:345:662)
-
Brodie MJ, Richens A, Yuen AW. UK Lamotngine/Carbamazepine Monotherapy Trial Group. Double-blind companion of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995;345: 476-9 (published erratum appears in Lancet 1995:345:662).
-
(1995)
Lancet
, vol.345
, pp. 476-479
-
-
Brodie, M.J.1
Richens, A.2
Yuen, A.W.3
-
18
-
-
0029896518
-
Standardisation of a self-report questionnaire for use in evaluating cognitive, affective, and behavioural sidc-effects of antiepileptic drug treatments
-
Gillham R, Baker G, Thompson P, Birbcck K, McGuire A, Iomlinson L. et al. Standardisation of a self-report questionnaire for use in evaluating cognitive, affective, and behavioural sidc-effects of antiepileptic drug treatments. Epilepsy Res 1996;24:47-55.
-
(1996)
Epilepsy Res
, vol.24
, pp. 47-55
-
-
Gillham, R.1
Baker, G.2
Thompson, P.3
Birbcck, K.4
McGuire, A.5
Iomlinson, L.6
-
19
-
-
0028598399
-
Intractable epilepsy in children: The efficacy ol lamotrigine treatment, including non-sei/urc-rclated benefits
-
Uvebrant P, Bauziene R. Intractable epilepsy in children: The efficacy ol lamotrigine treatment, including non-sei/urc-rclated benefits. Ncuropcdiatrics 1994;25:284-9.
-
(1994)
Ncuropcdiatrics
, vol.25
, pp. 284-289
-
-
Uvebrant, P.1
Bauziene, R.2
-
20
-
-
0029146313
-
The efficacy of lamotrigine on seizure control in 34 children, adolescents, and young adults with intellectual and physical disability
-
Buchanan N. The efficacy of lamotrigine on seizure control in 34 children, adolescents, and young adults with intellectual and physical disability. Seizure 1995;4:233-6.
-
(1995)
Seizure
, vol.4
, pp. 233-236
-
-
Buchanan, N.1
-
21
-
-
0031405012
-
Behavioral and cognitive effects of bmotrigine
-
Meador KJ, Baker GA. Behavioral and cognitive effects of bmotrigine. J Child Neurol 1997;12(Suppl l):S44-7.
-
(1997)
J Child Neurol
, vol.12
, Issue.1
-
-
Meador, K.J.1
Baker, G.A.2
-
23
-
-
0027231133
-
Memory and psychomotor effects of oxcarbazcpine in healthy human volunteers
-
Curran HV. Java R. Memory and psychomotor effects of oxcarbazcpine in healthy human volunteers. EurJ Clin Pharmacol 1993;44: 529-33.
-
(1993)
Eurj Clin Pharmacol
, vol.44
, pp. 529-533
-
-
Curran, H.V.1
Java, R.2
-
24
-
-
0029899584
-
Cognitive adverse effects of anti epileptic drugs
-
Kalviainen R. Aikia M. Riekkinen PJ. Cognitive adverse effects of anti epileptic drugs. CNS Drugs 1996;6:358-68.
-
(1996)
CNS Drugs
, vol.6
, pp. 358-368
-
-
Kalviainen, R.1
Aikia, M.2
Riekkinen, P.J.3
-
25
-
-
0028232327
-
Antiparkinsonian effects of rcnuceimde hydrochloride, a glutamate antagonist, in rodent and pnmatc models of Parkinson's disease commcne
-
Greenamyrc JT, Eller RV, Zhang Z, Ovadia A, Kurlan R, Gash DM. Antiparkinsonian effects of rcnuceimde hydrochloride, a glutamate antagonist, in rodent and pnmatc models of Parkinson's disease commcne. Ann Neurol 1994;35:655-61.
-
(1994)
Ann Neurol
, vol.35
, pp. 655-661
-
-
Greenamyrc, J.T.1
Eller, R.V.2
Zhang, Z.3
Ovadia, A.4
Kurlan, R.5
Gash, D.M.6
-
26
-
-
0028303908
-
Neuropsychological effects of dagabine, a potential new antiepileptic drug
-
Sveinbjomsdottir S, Sander JW, Patsalos PN, Upton D, Thompson PJ, Duncan JS. Neuropsychological effects of dagabine, a potential new antiepileptic drug. Seizure 1994:3:29-35.
-
(1994)
Seizure
, vol.3
, pp. 29-35
-
-
Sveinbjomsdottir, S.1
Sander, J.W.2
Patsalos, P.N.3
Upton, D.4
Thompson, P.J.5
Duncan, J.S.6
-
27
-
-
0030946472
-
Cognitive and quality of life effects of diffenng dosages of ciagabine in epilepsy
-
D’Klrill CB, Arnett JL, Sommerville KW, Shu V. Cognitive and quality of life effects of diffenng dosages of ciagabine in epilepsy. Neurology 1997; 48:1025-31.
-
(1997)
Neurology
, vol.48
, pp. 1025-1031
-
-
D’Klrill, C.B.1
Arnett, J.L.2
Sommerville, K.W.3
Shu, V.4
-
28
-
-
0031418448
-
Topiramate: A review of preclinieal, pharmacokinetic and clinical data
-
RosenfeKl WE. Topiramate: A review of preclinieal, pharmacokinetic and clinical data. Clinical Therapeutics 1997;19:1294-30.
-
(1997)
Clinical Therapeutics
, vol.19
, pp. 1294-1330
-
-
Rosenfekl, W.E.1
-
29
-
-
85026168741
-
Topiramate TPS-TR Study Team. Assessing cognitive effects of a new AF.D without the bias of practice effects
-
Meador KJ, Kaiuin M. Topiramate TPS-TR Study Team. Assessing cognitive effects of a new AF.D without the bias of practice effects. Epilepsia 1997:38(Suppl 3):60.
-
(1997)
Epilepsia
, vol.38
, Issue.3
-
-
Meador, K.J.1
Kaiuin, M.2
-
30
-
-
0030248894
-
Vigjbatriii and behaviour disorders. A retrospective survey
-
Thomas L, Trimble M, Schmitz B, Ring H. Vigjbatriii and behaviour disorders. A retrospective survey. Epilepsy Res 1996;25:21-7.
-
(1996)
Epilepsy Res
, vol.25
, pp. 21-27
-
-
Thomastrimble, L.1
Schmitz, M.B.2
Ring, H.3
-
31
-
-
0027763487
-
Evaluation of the effects of vigabatrin on cognitive abilities and quality of life in epilepsy
-
Dodrill CB, Arnett JL. Sommerville KW, Sussman NM. Evaluation of the effects of vigabatrin on cognitive abilities and quality of life in epilepsy. Neurology 1993;43:2501-7.
-
(1993)
Neurology
, vol.43
, pp. 2501-2507
-
-
Dodrill, C.B.1
Arnett, J.L.2
Sommerville, K.W.3
Sussman, N.M.4
-
32
-
-
0028888579
-
Sussman NM Effects of differing dosages oi vigabatrin (Sabnl) on cognitive abilities and quality of life in epilepsy
-
Dodrill CB, Arnett JL, Sommerville KW, Sussman NM Effects of differing dosages oi vigabatrin (Sabnl) on cognitive abilities and quality of life in epilepsy. Epilepsia 1995;36:164-73.
-
(1995)
Epilepsia
, vol.36
, pp. 164-173
-
-
Dodrill, C.B.1
Arnett, J.L.2
Sommerville, K.W.3
-
33
-
-
0027764555
-
Effect of vigabatrin on sedation and cognitive function in patients with refractory epilepsy
-
Gillham RA. Blacklaw J, McKcc PJ, Brodie MJ. Effect of vigabatrin on sedation and cognitive function in patients with refractory epilepsy. J Neurol Neurosurg Psychiatry 1993;56:1271-5.
-
(1993)
J Neurol Neurosurg Psychiatry
, vol.56
, pp. 1271-1275
-
-
Gillham, R.A.1
Blacklaw, J.2
McKcc, P.J.3
Brodie, M.J.4
-
34
-
-
0028610257
-
Effects of vigabatrin on partial seizures and cognitive function
-
Gmnewald RA, Thompson PJ, Corcoran R, Cordcn Z, Jackson CD, Duncan JS. Effects of vigabatrin on partial seizures and cognitive function. J Neurol Neurosurg Psychiatry 1994;57:1057-63.
-
(1994)
J Neurol Neurosurg Psychiatry
, vol.57
, pp. 1057-1063
-
-
Gmnewald, R.A.1
Thompson, P.J.2
Corcoran, R.3
Jackson, C.D.4
Duncan, J.S.5
-
35
-
-
0022470661
-
Psychophysiological and psychometric studies after manipulating the GABA system by vigabatrin
-
Salem B, Grunbcrger J. Linzmayer L. Schwartz JJ, Haegele KD. Schechter PJ. Psychophysiological and psychometric studies after manipulating the GABA system by vigabatrin. a GABA-transaminase inhibitor. ini I Psychophysiol 1986;4:63-80.
-
(1986)
A Gaba-Transaminase Inhibitor. Ini I Psychophysiol
, vol.4
, pp. 63-80
-
-
Salem, B.1
Grunbcrger, J.2
Linzmayer, L.3
Schwartz, J.J.4
Haegele, K.D.5
Schechter, P.J.6
-
36
-
-
0029143292
-
Vigabatrin vs carbamazcpine monotherapy in patients with newly diagnosed epilepsy: A randomized, controlled study
-
Kalviaincn R, Aikia M. Saukkonen AM, Mervaala E. Riekkinen PJ. Vigabatrin vs carbamazcpine monotherapy in patients with newly diagnosed epilepsy: A randomized, controlled study. Arch Neurol 1995; 52:989-96.
-
(1995)
Arch Neurol
, vol.52
, pp. 989-996
-
-
Kalviaincn, R.1
Aikia, M.2
Saukkonen, A.M.3
Mervaala, E.4
Riekkinen, P.J.5
-
37
-
-
0023066590
-
Zoimamide (CI-912) and cognition: Results from preliminary study
-
Berent S, Sackcllares JC, Giordani B, Wagner JG, Donofrio PP, Abou-Khalil B. Zoimamide (CI-912) and cognition: Results from preliminary study. Epilepsia 1987;28:61-7.
-
(1987)
Epilepsia
, vol.28
, pp. 61-67
-
-
Berentsackcllares, S.1
Giordani Wagner, J.C.B.J.G.2
Donofrio, P.P.3
Abou-Khalil, B.4
-
38
-
-
84939300594
-
Craft B Results of a nationwide Veterans Administration Cooperative Study comparing the efficacy and toxicity of carbamazcpine, phenobarbit.II, phenytoin. And primidone
-
Smith L. B, Mattson RH, Cramer JA, Collins JF, Novelly R. Craft B Results of a nationwide Veterans Administration Cooperative Study comparing the efficacy and toxicity of carbamazcpine, phenobarbit.il, phenytoin. and primidone. Epilepsia 1987;28(Suppl 3):850-8.
-
(1987)
Epilepsia
, vol.28
, Issue.3
, pp. 850-858
-
-
Smith, L.B.1
Mattson, R.H.2
Cramercollins, J.A.3
Novelly, J.F.R.4
|